Ustekinumab safe and effective for psoriatic arthritis
Phase 3 data from the SUMMIT trial evaluating ustekinumab (Stelara) found it safe and effective in patients with psoriatic arthritis. Ustekinumab blocks the effects of IL12 and IL 23. The drug is FDA approved for psoriasis and investigational for psoriatic arthritis.
Comment: Whether this drug will find widespread use in psoriatic arthritis is going to be interesting to see.
Excerpt from: Blog – Arthritis Treatment Center